These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21453301)

  • 1. Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study.
    Shah SM; Carey IM; Owen CG; Harris T; Dewilde S; Cook DG
    Br J Clin Pharmacol; 2011 Jul; 72(1):157-61. PubMed ID: 21453301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can analyses of electronic patient records be independently and externally validated? Study 2--the effect of β-adrenoceptor blocker therapy on cancer survival: a retrospective cohort study.
    Springate DA; Ashcroft DM; Kontopantelis E; Doran T; Ryan R; Reeves D
    BMJ Open; 2015 Apr; 5(4):e007299. PubMed ID: 25869690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological intervention in hypertension using beta-blockers: Real-world evidence for long-term effectiveness.
    Sabidó M; Hohenberger T; Grassi G
    Pharmacol Res; 2018 Apr; 130():191-197. PubMed ID: 29366925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenergic receptor blockers and liver cancer mortality in a national cohort of hepatocellular carcinoma patients.
    Udumyan R; Montgomery S; Duberg AS; Fang F; Valdimarsdottir U; Ekbom A; Smedby KE; Fall K
    Scand J Gastroenterol; 2020 May; 55(5):597-605. PubMed ID: 32412855
    [No Abstract]   [Full Text] [Related]  

  • 5. Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis.
    Weberpals J; Jansen L; van Herk-Sukel MPP; Kuiper JG; Aarts MJ; Vissers PAJ; Brenner H
    Eur J Epidemiol; 2017 Nov; 32(11):1019-1031. PubMed ID: 28864947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy.
    Wang HM; Liao ZX; Komaki R; Welsh JW; O'Reilly MS; Chang JY; Zhuang Y; Levy LB; Lu C; Gomez DR
    Ann Oncol; 2013 May; 24(5):1312-9. PubMed ID: 23300016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer.
    Watkins JL; Thaker PH; Nick AM; Ramondetta LM; Kumar S; Urbauer DL; Matsuo K; Squires KC; Coleman RL; Lutgendorf SK; Ramirez PT; Sood AK
    Cancer; 2015 Oct; 121(19):3444-51. PubMed ID: 26301456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink.
    Hagberg KW; Sahasrabuddhe VV; McGlynn KA; Jick SS
    Pharmacotherapy; 2016 Feb; 36(2):187-95. PubMed ID: 26846893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness comparison of cardio-selective to non-selective β-blockers and their association with mortality and morbidity in end-stage renal disease: a retrospective cohort study.
    Shireman TI; Mahnken JD; Phadnis MA; Ellerbeck EF
    BMC Cardiovasc Disord; 2016 Mar; 16():60. PubMed ID: 27012911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer.
    Giampieri R; Scartozzi M; Del Prete M; Faloppi L; Bianconi M; Ridolfi F; Cascinu S
    Medicine (Baltimore); 2015 Jun; 94(24):e719. PubMed ID: 26091452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of urothelial cancer death among people using antihypertensive drugs-a cohort study from Finland.
    Santala EEE; Kotsar A; Veitonmäki T; Tammela TLJ; Murtola TJ
    Scand J Urol; 2019 Aug; 53(4):185-192. PubMed ID: 31250699
    [No Abstract]   [Full Text] [Related]  

  • 12. Elucidating the role of incidental use of beta-blockers in patients with metastatic brain tumors in controlling tumor progression and survivability.
    Bir SC; Kalakoti P; Ahmed O; Bollam P; Nanda A
    Neurol India; 2015; 63(1):19-23. PubMed ID: 25751464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
    Bakris GL; Cooper-Dehoff RM; Zhou Q; Kupfer S; Champion A; Pepine CJ;
    Am J Cardiovasc Drugs; 2007; 7 Suppl 1():25-9. PubMed ID: 19845074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blocker usage and breast cancer survival: a nested case-control study within a UK clinical practice research datalink cohort.
    Cardwell CR; Coleman HG; Murray LJ; Entschladen F; Powe DG
    Int J Epidemiol; 2013 Dec; 42(6):1852-61. PubMed ID: 24536096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus in treated hypertension: incidence, predictive factors and the impact of non-selective beta-blockers and thiazide diuretics during 15 years treatment of middle-aged hypertensive men in the Primary Prevention Trial Göteborg, Sweden.
    Samuelsson O; Hedner T; Berglund G; Persson B; Andersson OK; Wilhelmsen L
    J Hum Hypertens; 1994 Apr; 8(4):257-63. PubMed ID: 7912734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blockers have no impact on survival in pancreatic ductal adenocarcinoma prior to cancer diagnosis.
    Yang A; Zylberberg HM; Rustgi SD; Amin SP; Bar-Mashiah A; Boffetta P; Lucas AL
    Sci Rep; 2021 Jan; 11(1):1038. PubMed ID: 33441781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of beta blockers on epithelial ovarian cancer survival.
    Diaz ES; Karlan BY; Li AJ
    Gynecol Oncol; 2012 Nov; 127(2):375-8. PubMed ID: 22819786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blockers for hypertension.
    Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Opie LH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002003. PubMed ID: 28107561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of alpha1-adrenoceptor antagonist exposure on prostate cancer incidence: an observational cohort study.
    Harris AM; Warner BW; Wilson JM; Becker A; Rowland RG; Conner W; Lane M; Kimbler K; Durbin EB; Baron AT; Kyprianou N
    J Urol; 2007 Nov; 178(5):2176-80. PubMed ID: 17870114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of beta-blockers and survival among hypertensive patients with renal cell carcinoma.
    Parker WP; Lohse CM; Zaid HB; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Urol Oncol; 2017 Jan; 35(1):36.e1-36.e6. PubMed ID: 27687543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.